Alliance Fiber Optic Products (NASDAQ:AFOP) CEO Peter C. Chang sold 203,332 shares of the company’s stock in a transaction that occurred on Wednesday, May 28th. The shares were sold at an average price of $21.06, for a total value of $4,282,171.92. Following the sale, the chief executive officer now directly owns 1,474,640 shares in the company, valued at approximately $31,055,918. Alliance Fiber Optic Products Inc (NASDAQ:AFOP) net profit margin is 24.80%and weekly performance is -1.70%. On last trading day company shares ended up $20.28. Analysts mean target price for the company is $89789. Alliance Fiber Optic Products Inc (NASDAQ:AFOP) distance from 50-day simple moving average (SMA50) is 14.78%.
Zogenix, Inc. (NASDAQ:ZGNX) announced that Stephen Farr, Ph.D., President, and Ann Rhoads, Chief Financial Officer, will be presenting at the Jefferies 2014 Global Healthcare Conference in New York City on June 4, 2014. Zogenix, Inc. (NASDAQ:ZGNX) shares advanced 5.99% in last trading session and ended the day on $2.30. ZGNX Gross Margin return on assets is -127.10%. Zogenix, Inc. (NASDAQ:ZGNX) quarterly performance is -47.13%.
May 22, 2014, Gogo Inc (NASDAQ:GOGO), announced that it has received an STC from the FAA and certification from the Japanese Civil Aviation Bureau (JCAB) – the aviation authority in Japan – to install Gogo’s Ku-satellite based connectivity service on Japan Airlines’ 767-300 aircraft. The 767-300 is the third aircraft type in JAL’s fleet to receive FAA and JCAB approval for installation. Gogo Inc (NASDAQ:GOGO) shares moved down -3.11% in last trading session and was closed at $18.09, while trading in range of $17.40 – $18.85. Gogo Inc (NASDAQ:GOGO) year to date (YTD) performance is -27.12%.
On May 28, TherapeuticsMD, Inc. (NYSE MKT:TXMD), announced the availability of the newly reformulated vitaMedMD® branded prescription prenatal vitamin, vitaMedMD RediChew™ Rx, and the BocaGreenMD® generic prescription prenatal vitamin Prena1 Chew. vitaMedMD RediChew Rx and Prena1 Chew are small, vanilla flavored, chewable prenatal vitamin tablets that dissolve quickly and are taken once daily. TherapeuticsMD Inc (NYSEMKT:TXMD) ended the last trading day at $4.06. Company weekly volatility is calculated as 6.48% and price to cash ratio as 13.01. TherapeuticsMD Inc (NYSEMKT:TXMD) showed a positive weekly performance of 5.73%.
Nimble Storage Inc (NYSE:NMBL) received a pair of analyst actions on Friday. Sterne Agee increased its price target on the stock to $44, increased its estimates and set a “buy” rating. The firm noted the company has strong sales momentum. Nimble Storage Inc (NYSE:NMBL) shares moved up -5.62% in last trading session and was closed at $25.37, while trading in range of $23.55 – $29.13. Nimble Storage Inc (NYSE:NMBL) year to date (YTD) performance is -44.00%.